Quarles LD[au] - Search Results

Year	Number of Results
1985	2
1986	3
1988	3
1989	2
1990	2
1991	8
1992	6
1993	4
1994	4
1995	4
1996	4
1997	7
1998	3
1999	7
2000	3
2001	7
2002	6
2003	10
2004	6
2005	9
2006	7
2007	9
2008	11
2009	7
2010	11
2011	9
2012	14
2013	9
2014	5
2015	5
2016	10
2017	5
2018	10
2019	7
2020	4
2021	4
2022	0

1

Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development.

Li H, Xiao Z, Quarles LD, Li W. Li H, et al. Among authors: quarles ld. Curr Med Chem. 2021;28(8):1489-1507. doi: 10.2174/0929867327666200330142432. Curr Med Chem. 2021. PMID: 32223730 Free PMC article. Review.

2

FGF23 from bench to bedside.

Kovesdy CP, Quarles LD. Kovesdy CP, et al. Among authors: quarles ld. Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1168-74. doi: 10.1152/ajprenal.00606.2015. Epub 2016 Feb 10. Am J Physiol Renal Physiol. 2016. PMID: 26864938 Free PMC article. Review.

3

[FGF23 and the heart].

Ezumba I, Quarles LD, Kovesdy CP. Ezumba I, et al. Among authors: quarles ld. G Ital Nefrol. 2014 Nov-Dec;31(6):gin/31.6.12. G Ital Nefrol. 2014. PMID: 25504170 Free PMC article. Review.

4

The carboxylation status of osteocalcin has important consequences for its structure and dynamics.

Kapoor K, Pi M, Nishimoto SK, Quarles LD, Baudry J, Smith JC. Kapoor K, et al. Among authors: quarles ld. Biochim Biophys Acta Gen Subj. 2021 Mar;1865(3):129809. doi: 10.1016/j.bbagen.2020.129809. Epub 2020 Dec 17. Biochim Biophys Acta Gen Subj. 2021. PMID: 33340588 Review.

5

Multiple faces of fibroblast growth factor-23.

Han X, Quarles LD. Han X, et al. Among authors: quarles ld. Curr Opin Nephrol Hypertens. 2016 Jul;25(4):333-42. doi: 10.1097/MNH.0000000000000240. Curr Opin Nephrol Hypertens. 2016. PMID: 27219044 Free PMC article. Review.

6

Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions.

Quarles LD. Quarles LD. Curr Opin Nephrol Hypertens. 2019 Jan;28(1):16-25. doi: 10.1097/MNH.0000000000000467. Curr Opin Nephrol Hypertens. 2019. PMID: 30451736 Free PMC article. Review.

7

Role of Fibroblast Growth Factor-23 in Innate Immune Responses.

Fitzpatrick EA, Han X, Xiao Z, Quarles LD. Fitzpatrick EA, et al. Among authors: quarles ld. Front Endocrinol (Lausanne). 2018 Jun 12;9:320. doi: 10.3389/fendo.2018.00320. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29946298 Free PMC article. Review.

8

FGF-23 Deficiency Impairs Hippocampal-Dependent Cognitive Function.

Laszczyk AM, Nettles D, Pollock TA, Fox S, Garcia ML, Wang J, Quarles LD, King GD. Laszczyk AM, et al. Among authors: quarles ld. eNeuro. 2019 Mar 22;6(2):ENEURO.0469-18.2019. doi: 10.1523/ENEURO.0469-18.2019. eCollection 2019 Mar-Apr. eNeuro. 2019. PMID: 30911673 Free PMC article.

9

GPRC6A: Jack of all metabolism (or master of none).

Pi M, Nishimoto SK, Quarles LD. Pi M, et al. Among authors: quarles ld. Mol Metab. 2016 Dec 21;6(2):185-193. doi: 10.1016/j.molmet.2016.12.006. eCollection 2017 Feb. Mol Metab. 2016. PMID: 28180060 Free PMC article. Review.

10

Physiological mechanisms and therapeutic potential of bone mechanosensing.

Xiao Z, Quarles LD. Xiao Z, et al. Among authors: quarles ld. Rev Endocr Metab Disord. 2015 Jun;16(2):115-29. doi: 10.1007/s11154-015-9313-4. Rev Endocr Metab Disord. 2015. PMID: 26038304 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results